The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial | Zendy

Philippe Menasché | Zendy; Ottavio Alfieri | Zendy; Stefan Janssens | Zendy; William J. McKenna | Zendy; Hermann Reichenspurner | Zendy; Ludovic Trinquart | Zendy; JeanThomas Vilquin | Zendy; JeanPierre Marolleau | Zendy; Barbara Seymour | Zendy; Jérôme Larghero | Zendy; Stephen Lake | Zendy; Gilles Châtellier | Zendy; Scott D. Solomon | Zendy; Michel Desnos | Zendy; Albert Hagège | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial

Author(s) -

Philippe Menasché,

Ottavio Alfieri,

Stefan Janssens,

William J. McKenna,

Hermann Reichenspurner,

Ludovic Trinquart,

JeanThomas Vilquin,

JeanPierre Marolleau,

Barbara Seymour,

Jérôme Larghero,

Stephen Lake,

Gilles Châtellier,

Scott D. Solomon,

Michel Desnos,

Albert Hagège

Publication year - 2008

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.734103

Subject(s) - medicine , ejection fraction , placebo , cardiology , interquartile range , myocardial infarction , adverse effect , ischemic cardiomyopathy , heart failure , cardiac function curve , scars , surgery , pathology , alternative medicine

Phase I clinical studies have demonstrated the feasibility of implanting autologous skeletal myoblasts in postinfarction scars. However, they have failed to determine whether this procedure was functionally effective and arrhythmogenic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research